- Home
- CARM vs SINT Comparison
CARM vs SINT Comparison
Compare CARM & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- SINT
- Stock Information
- Founded
- CARM 2016
- SINT 1996
- Country
- CARM United States
- SINT United States
- Employees
- CARM N/A
- SINT N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- CARM Health Care
- SINT Health Care
- Exchange
- CARM Nasdaq
- SINT Nasdaq
- Market Cap
- CARM 7.7M
- SINT 7.9M
- IPO Year
- CARM N/A
- SINT 2014
- Fundamental
- Price
- CARM $0.19
- SINT $2.71
- Analyst Decision
- CARM Hold
- SINT Strong Buy
- Analyst Count
- CARM 5
- SINT 1
- Target Price
- CARM $0.90
- SINT $28.00
- AVG Volume (30 Days)
- CARM 956.5K
- SINT 334.9K
- Earning Date
- CARM 05-13-2025
- SINT 05-15-2025
- Dividend Yield
- CARM N/A
- SINT N/A
- EPS Growth
- CARM N/A
- SINT N/A
- EPS
- CARM N/A
- SINT N/A
- Revenue
- CARM $19,964,000.00
- SINT $2,569,000.00
- Revenue This Year
- CARM N/A
- SINT $3.26
- Revenue Next Year
- CARM N/A
- SINT $21.87
- P/E Ratio
- CARM N/A
- SINT N/A
- Revenue Growth
- CARM 32.45
- SINT N/A
- 52 Week Low
- CARM $0.14
- SINT $1.71
- 52 Week High
- CARM $1.90
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- CARM 44.76
- SINT 48.09
- Support Level
- CARM $0.14
- SINT $2.51
- Resistance Level
- CARM $0.20
- SINT $2.85
- Average True Range (ATR)
- CARM 0.02
- SINT 0.29
- MACD
- CARM 0.00
- SINT -0.05
- Stochastic Oscillator
- CARM 71.47
- SINT 16.95
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.